NFX-179 Gel ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
34神経線維腫症2

34. 神経線維腫症


臨床試験数 : 133 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05005845
(ClinicalTrials.gov)
September 20, 20212/8/2021NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous NeurofibromasCutaneous Neurofibroma;Neurofibromatosis 1Drug: NFX-179 gel;Drug: Vehicle gelNFlection Therapeutics, Inc.NULLActive, not recruiting18 YearsN/AAll199Phase 2United States
2NCT04435665
(ClinicalTrials.gov)
August 21, 20208/6/2020NFX-179 Topical Gel Treatment in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2a Study to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Activity of NFX-179 Gel in Subjects With Cutaneous NeurofibromasNeurofibromatosis 1;Cutaneous NeurofibromaDrug: NFX-179 Gel;Drug: Vehicle GelNFlection Therapeutics, Inc.NULLCompleted18 YearsN/AAll48Phase 2United States